Intraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma
This study aims to get clear and organised information about how a type of brain tumour called medulloblastoma starts and grows. Doctors will closely observe these tumours during surgery. They want to compare what they see during the operation with information from brain scans and genetic tests. The goal is to better understand how medulloblastoma develops and how useful scans can be in predicting its features. Patients, both children and adults, who are having surgery for medulloblastoma at a specialist hospital will be included. This research hopes to improve our understanding of medulloblastoma, which helps doctors make better decisions about treatment.
At a glance
What is this study about?
This research is looking into a type of brain tumour called medulloblastoma. It affects both children and adults. The main idea behind this study is to get a really clear picture of where these tumours start in the brain and how they grow. At the moment, doctors use brain scans and genetic tests to understand these tumours, but this study wants to see how well these methods match up with what a surgeon actually sees during an operation.
Imagine doctors want to build a more accurate map of these tumours. By looking closely during surgery, they can add extremely detailed information to their existing maps from scans and genetic tests. This clearer picture could help them understand why these tumours form in certain places and grow in particular ways. Ultimately, a better understanding can lead to more effective treatments and better outlooks for patients in the future.
This study is mostly about gathering information. It's not testing a new drug or treatment. Instead, it's collecting careful observations during surgery and linking them to other important medical information. The hope is that this detailed data will help doctors make even more accurate predictions about how a patient's medulloblastoma might behave, which helps tailor treatments specifically for them.
Key takeaways
- This study helps doctors understand how medulloblastoma starts and grows.
- It involves careful observations during planned surgery.
- Data from surgery is compared with brain scans and genetic tests.
- Both children and adults with medulloblastoma can take part.
- The goal is to improve future understanding and care for patients.
Who may be eligible?
To be part of this study, you or your child would need to be having surgery for medulloblastoma at a hospital that specialises in treating brain tumours in children and young people. The study includes both children (under 18) and adults (18 and over) who have been diagnosed with medulloblastoma.
There are a few reasons why someone might not be able to join. For example, if there's a lot of bleeding in the tumour before the operation, it can make it hard to get clear brain scans, which are important for this study. Also, if there's a problem during surgery that makes it difficult for the surgeon to see the tumour clearly, then participation might not be possible.
Finally, the study needs to confirm that the tumour is definitely medulloblastoma after it's been removed and examined closely by pathologists. If it turns out to be a different type of tumour, then that patient wouldn't be included in this specific study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Am I, or my child, having surgery for medulloblastoma?
- Is this surgery happening at a specialist children's brain tumour centre?
- Do I understand that this study is observational, not a treatment trial?
- Do I want to help improve understanding of medulloblastoma for future patients?
What does participation involve?
If you or your child take part in this study, you won't have any extra procedures or medicines. The main thing that will happen is that during the planned surgery for medulloblastoma, a very experienced children's brain surgeon will carefully observe and note down exactly where the tumour started and how it was growing. This is a normal part of the surgical process, but in this study, the observations are done in a very specific and detailed way.
After the surgery, specialist doctors who look at brain scans will also carefully examine your or your child's brain scans taken before and after the operation. They will be looking for the same information about where the tumour started and how it grew. This will help the researchers compare what was seen during surgery with what the scans show. This study does not involve any additional visits or longer hospital stays.
Potential risks and benefits
Locations (4)
- Department of Neurosurgery, Medical University of ViennaVerified postcodeVienna, Austria
- Department of Neurosurgery, Charité BerlinVerified postcodeBerlin, Germany
- Section of Pediatric Neurosurgery, University Hospital of TuebingenVerified postcodeTübingen, Germany
- Department of Neurosurgery, Princess Maxima Centre for Pediatric OncologyVerified postcodeUtrecht, Netherlands
Common questions
What is medulloblastoma?
Medulloblastoma is a type of brain tumour that typically grows in the lower back part of the brain, affecting both children and adults.
Will I receive a new treatment in this study?
No, this study is about observing and gathering information, not testing new treatments or medicines.
Who is running this study?
The study is being carried out by brain surgeons and specialists at hospitals that have a lot of experience treating children's brain tumours.
Will my surgery be different if I join the study?
The surgery itself won't be different. The surgeon will simply take very detailed notes during the operation.
Can I leave the study if I change my mind?
Yes, you can decide to stop participating in the study at any time without it affecting your medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.